Mesenchymal stem cells as a treatment strategy for coronavirus disease 2019 (COVID-19): need for authority regulations and clinical guidelines

AC Tufan - Current stem cell research & therapy, 2021 - ingentaconnect.com
The cause of Coronavirus Disease 2019 (COVID-19) known as the Severe Acute
Respiratory Syndrome Coronavirus 2 (SARS-CoV-2, formerly designated 2019-nCoV) was …
被引用次数：8 相关文章

Mesenchymal Stem Cells as a Treatment Strategy for Coronavirus Disease 2019 (COVID-19): Need for Authority Regulations and Clinical Guidelines.

AC Tufan - Current Stem Cell Research & Therapy, 2021 - europepmc.org
The cause of Coronavirus Disease 2019 (COVID-19) known as the Severe Acute
Respiratory Syndrome Coronavirus 2 (SARS-CoV-2, formerly designated 2019-nCoV) was …

Mesenchymal Stem Cells as a Treatment Strategy for Coronavirus Disease 2019 (COVID-19): Need for Authority Regulations and Clinical Guidelines

A TUFAN - Current stem cell research & therapy, 2021 - avesis.aybu.edu.tr
Mesenchymal Stem Cells as a Treatment Strategy for Coronavirus Disease 2019 (COVID-19):
Need for Authority Regulations and Clinical Guidelines | AVESİS Ankara Yıldırım Beyazıt …

Mesenchymal Stem Cells as a Treatment Strategy for Coronavirus Disease 2019 (COVID-19): Need for Authority Regulations and Clinical Guidelines

AC Tufan - Current stem cell research & therapy, 2021 - pubmed.ncbi.nlm.nih.gov
The cause of Coronavirus Disease 2019 (COVID-19) known as the Severe Acute
Respiratory Syndrome Coronavirus 2 (SARS-CoV-2, formerly designated 2019-nCoV) was …